Par Drugs and Chemicals Limited (NSE:PAR)

Par Drugs and Chemicals Revenue

In the fiscal year ending March 31, 2026, Par Drugs and Chemicals had annual revenue of 1.04B INR with 2.66% growth. Par Drugs and Chemicals had revenue of 196.11M in the quarter ending March 31, 2026, a decrease of -12.18%.

• Revenue: 1.04B
• Revenue Growth: +2.66%
• P/S Ratio: 1.12
• Revenue / Employee: 8.57M
• Employees: 121
• Market Cap: 1.16B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.04B	26.82M	2.66%
Mar 31, 2025	1.01B	53.33M	5.58%
Mar 31, 2024	956.40M	-1.08M	-0.11%
Mar 31, 2023	957.49M	206.74M	27.54%
Mar 31, 2022	750.74M	143.23M	23.58%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 20, 2026

Data Sources Report a data error